Arbutus Biopharma Corp (ABUS)

Finanzdaten der Arbutus Biopharma Corp-Aktie (ABUS)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	53.95% 2.145	4.658	4.651	6.687	6.245
Operating Expenses	12.68% 22.89	26.22	23.04	24.10	28.81
Interest Income/Expense	4.35% 0.044	0.046	0.171	0.198	0.309
Benefits Costs and Expenses	380.81% -69.53	24.76	21.75	23.03	-75.85
Costs And Expenses	7.87% 26.71	24.76	21.75	23.03	28.62
Operating Income/Loss	3.76% -20.75	-21.56	-18.39	-17.41	-22.56
Nonoperating Income/Loss	1.31% 1.435	1.454	1.291	1.074	0.63
Income/Loss From Continuing Operations Before Tax	456.54% 71.68	-20.10	-17.09	-16.34	82.10
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	3.94% -19.31	-20.10	-17.09	-16.34	-21.93
Net Income/Loss	3.94% -19.31	-20.10	-17.09	-16.34	-21.93
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.48% 0.8751	167.51	166.06	161.64	1.5533
Diluted Average Shares	99.48% 0.8751	167.51	166.06	161.64	1.5533
Basic Earnings Per Share	0.00% -0.12	-0.12	-0.10	-0.10	-0.14
Diluted Earnings Per Share	0.00% -0.12	-0.12	-0.10	-0.10	-0.14
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-